Cargando…

Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy

BACKGROUND: Bone Scan Index (BSI) is a quantitative measurement of tumour burden in the skeleton calculated from bone scan images. When analysed at the time of diagnosis, it has been shown to provide prognostic information on survival in men with metastatic prostate cancer (PCa). In this study, we e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reza, Mariana, Bjartell, Anders, Ohlsson, Mattias, Kaboteh, Reza, Wollmer, Per, Edenbrandt, Lars, Trägårdh, Elin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205473/ https://www.ncbi.nlm.nih.gov/pubmed/25386390 http://dx.doi.org/10.1186/s13550-014-0058-y

Ejemplares similares

A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer
por: Reza, Mariana, et al.
Publicado: (2018)

Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy
por: Kaboteh, Reza, et al.
Publicado: (2013)

Progression of bone metastases in patients with prostate cancer - automated detection of new lesions and calculation of bone scan index
por: Kaboteh, Reza, et al.
Publicado: (2013)

Prognosis of patients without perfusion defects with and without rest study in myocardial perfusion scintigraphy
por: Edenbrandt, Lars, et al.
Publicado: (2013)

RECOMIA—a cloud-based platform for artificial intelligence research in nuclear medicine and radiology
por: Trägårdh, Elin, et al.
Publicado: (2020)

AI-based detection of lung lesions in [(18)F]FDG PET-CT from lung cancer patients
por: Borrelli, Pablo, et al.
Publicado: (2021)

Artificial intelligence-aided CT segmentation for body composition analysis: a validation study
por: Borrelli, Pablo, et al.
Publicado: (2021)

The use of a proposed updated EARL harmonization of (18)F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations
por: Ly, John, et al.
Publicado: (2019)

Referring physicians underestimate the extent of abnormalities in final reports from myocardial perfusion imaging
por: Trägårdh, Elin, et al.
Publicado: (2012)

Freely available convolutional neural network-based quantification of PET/CT lesions is associated with survival in patients with lung cancer
por: Borrelli, Pablo, et al.
Publicado: (2022)

Automated artificial intelligence-based analysis of skeletal muscle volume predicts overall survival after cystectomy for urinary bladder cancer
por: Ying, Thomas, et al.
Publicado: (2021)

Analysis of regional bone scan index measurements for the survival of patients with prostate cancer
por: Kalderstam, Jonas, et al.
Publicado: (2014)

Perfusion vector—a new method to quantify myocardial perfusion scintigraphy images: a simulation study with validation in patients
por: Minarik, David, et al.
Publicado: (2015)

Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index
por: Lindgren Belal, Sarah, et al.
Publicado: (2023)

3D skeletal uptake of (18)F sodium fluoride in PET/CT images is associated with overall survival in patients with prostate cancer
por: Lindgren Belal, Sarah, et al.
Publicado: (2017)

Correction to: 3D skeletal uptake of (18)F sodium fluoride in PET/CT images is associated with overall survival in patients with prostate cancer
por: Belal, Sarah Lindgren, et al.
Publicado: (2019)

Deep learning‐based quantification of PET/CT prostate gland uptake: association with overall survival
por: Polymeri, Eirini, et al.
Publicado: (2019)

Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
por: Trägårdh, Elin, et al.
Publicado: (2022)

Detection of lymph node metastases in patients with prostate cancer: Comparing conventional and digital [(18)F]‐fluorocholine PET‐CT using histopathology as a reference
por: Bjöersdorff, Mimmi, et al.
Publicado: (2022)

Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
por: Anand, Aseem, et al.
Publicado: (2016)

Adding attenuation corrected images in myocardial perfusion imaging reduces the need for a rest study
por: Trägårdh, Elin, et al.
Publicado: (2013)

Small average differences in attenuation corrected images between men and women in myocardial perfusion scintigraphy: a novel normal stress database
por: Trägårdh, Elin, et al.
Publicado: (2011)

Automated classification of PET‐CT lesions in lung cancer: An independent validation study
por: Borrelli, Pablo, et al.
Publicado: (2022)

Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
por: Anand, Aseem, et al.
Publicado: (2022)

Nuclear medicine technologists are able to accurately determine when a myocardial perfusion rest study is necessary
por: Trägårdh, Elin, et al.
Publicado: (2012)

Post-reconstruction enhancement of [(18)F]FDG PET images with a convolutional neural network
por: Ly, John, et al.
Publicado: (2021)

Assessing the accuracy of [(18)F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
por: Ingvar, Jacob, et al.
Publicado: (2022)

When is reacquisition necessary due to high extra-cardiac uptake in myocardial perfusion scintigraphy?
por: Johansen, Allan, et al.
Publicado: (2013)

Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots
por: Abrahamsson, Per-Anders
Publicado: (2017)

Androgen deprivation therapy and side effects: are GnRH antagonists safer?
por: Freedland, Stephen J, et al.
Publicado: (2020)

Semi-automatic analysis of standard uptake values in serial PET/CT studies in patients with lung cancer and lymphoma
por: Ly, John, et al.
Publicado: (2012)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021)

Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases
por: Varenhorst, Eberhard, et al.
Publicado: (2016)

A simple statistical model for prediction of acute coronary syndrome in chest pain patients in the emergency department
por: Björk, Jonas, et al.
Publicado: (2006)

Diagnostic evaluation of three cardiac software packages using a consecutive group of patients
por: Johansson, Lena, et al.
Publicado: (2011)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Evaluation of inter-departmental variability of ejection fraction and cardiac volumes in myocardial perfusion scintigraphy using simulated data
por: Trägårdh, Elin, et al.
Publicado: (2015)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_8dupl8ho9tfj3haac537eeev6i